Polio elimination in Nigeria: A review

References

• Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Sutter RW. Survey of poliovirus antibodies in Kano, Northern Nigeria. Vaccine 2014; 32(12):1414-20; PMID:24041545; http://dx.doi.org/10.1016/j.vaccine.2013.08.060
   PubMed Web of Science ®Google Scholar
• CDC. Outbreaks following wild poliovirus importations — Europe, Africa, and Asia, January 2009 – September 2010. Morb Mortal Wkly Rep 2012; 59(43):PMID:22647710
   PubMedGoogle Scholar
• WHO. WHO, Progress towards poliomyelitis eradication in Nigeria, January 2012–September 2013. Wkly Epidemiological Record 2013; 51-52(88):545-56
   Google Scholar
• Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010; 172(11):1213-29; PMID:20978089; http://dx.doi.org/10.1093/aje/kwq320
   PubMed Web of Science ®Google Scholar
• Moturi EK, Porter KA, Wassilak SGF, Tangermann Rudolf H, Diop OM, Burns CC, Jafari H. Progress toward polio eradication — worldwide, 2013–2014. Morb Mortal Wkly Rep 2014; 63(21):468-72; PMID:24871252
   PubMed Web of Science ®Google Scholar
• Mundel T, Orenstein WA. No country is safe without global eradication of poliomyelitis. New Engl J Med 2013; 369(21):2045-6; PMID:24256383; http://dx.doi.org/10.1056/NEJMe1311591
   PubMed Web of Science ®Google Scholar
• Global Polio Eradication Initiative (GPEI). Global polio eradication initiative status report 30 April 2014. 2014.
   Google Scholar
• Roberts L. Vaccine-related polio outbreak in Nigeria Raises concerns. Science 2007; 317( September):2007; PMID:17901301; http://dx.doi.org/10.1126/science.317.5846.1842
   PubMed Web of Science ®Google Scholar
• Bhutta ZA. The last mile in global poliomyelitis eradication. Lancet 2011; 378(9791):549-52; PMID:21664681; http://dx.doi.org/10.1016/S0140-6736(11)60744-7
   PubMed Web of Science ®Google Scholar
• National Primary Healthcare Development Agency (NPHCDA). 2014 Nigeria polio eradication emergency plan. 2014; ( December 2013):1-69.
   Google Scholar
• Arita I, Nakane M. Road map for polio eradication–establishing the link with Millennium Development Goal no. 4 for child survival. Jap J Infect Dis 2008; 61(3):169-74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18503163; PMID:18503163
   PubMed Web of Science ®Google Scholar
• Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Grassly NC. Implications of a circulating vaccine-derived poliovirus in Nigeria. New Engl J Med 2010; 362(25):2360-9; PMID:20573924; http://dx.doi.org/10.1056/NEJMoa0910074
   PubMed Web of Science ®Google Scholar
• Heymann DL, Sutter RW, Aylward RB. A vision of a world without polio: the OPV cessation strategy. Biol: J Int Assoc Biol Stand 2006; 34(2):75-9; PMID:16682224; http://dx.doi.org/10.1016/j.biologicals.2006.03.005
   PubMed Web of Science ®Google Scholar
• Tomori O. From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives. Vaccine 2011; 29 Suppl 4:D145-8; PMID:22185830; http://dx.doi.org/10.1016/j.vaccine.2011.09.003
   PubMedGoogle Scholar
• National Primary Health Care Development Agency. (2012). National routine immunization strategic plan:12-14.
   Google Scholar
• Okeibunor JC, Akanmori BD, Balcha GM, Mihigo R, Vaz RM, Nshimirimana D. Enhancing access to immunization services and exploiting the benefits of recent innovations in the African region. Vaccine 2013; 31(37):3772-6; PMID:23800541; http://dx.doi.org/10.1016/j.vaccine.2013.06.038
   PubMed Web of Science ®Google Scholar
• Kamadjeu R. Tracking the polio virus down the Congo River: a case study on the use of Google Earth in public health planning and mapping. Int J Health Geographics 2009; 8:4; PMID:19161606; http://dx.doi.org/10.1186/1476-072X-8-4
   PubMed Web of Science ®Google Scholar
• Richardson G, Linkins RW, Eames MA, Wood DJ, Campbell PJ, Ankers E, Minor PD. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Bull World Health Org 1995; 73(6):769-77. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2486680&tool=pmcentrez&rendertype=abstract; PMID:8907770
   PubMed Web of Science ®Google Scholar
• Hennessey KA, Lago H, Diomande F, Akoua-koffi C, Caceres VM, Pallansch MA, Zuber PLF. Poliovirus vaccine shedding among persons with HIV in Abidjan. J Infect Dis 2005; 192(12):2124-2128
   PubMed Web of Science ®Google Scholar
• Manirakiza A, Picard E, Ngbale R, Menard D, Gouandjika-Vasilache I. OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic. BMC Res Notes 2010; 3( October 2001):136; PMID:20482773; http://dx.doi.org/10.1186/1756-0500-3-136
   PubMedGoogle Scholar
• Troy SB, Ferreyra-Reyes L, Huang C, Mahmud N, Lee Y-J, Canizales-Quintero S, Maldonado Y. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day. J Clin Microbiol 2011; 49(5):1777-83; PMID:21411577; http://dx.doi.org/10.1128/;JCM.02524-10
   PubMed Web of Science ®Google Scholar
• Más Lago P, Cáceres VM, Galindo MA, Gary HE, Valcarcel M, Barrios J, de Quadros CA. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol 2001; 30(5):1029-34. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11689516; PMID:11689516; http://dx.doi.org/10.1093/ije/30.5.1029
   PubMed Web of Science ®Google Scholar
• Giwa FJ, Olayinka AT, Ogunshola FT. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. Vaccine 2012; 30(48):6759-65; PMID:23000220; http://dx.doi.org/10.1016/j.vaccine.2012.09.023
   PubMed Web of Science ®Google Scholar
• Mangal TD, Aylward RB, Mwanza M, Gasasira A, Abanida E, Pate MA, Grassly NC. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study. Lancet Glob Health 2014; 2:e90-97; PMID:25104665; http://dx.doi.org/10.1016/S2214-109X(13)70168-2
   PubMed Web of Science ®Google Scholar
• Clements CJ, Greenough P, Shull D. How vaccine safety can become political–the example of polio in Nigeria. Current Drug Safety 2006; 1(1):117-9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18690921; PMID:18690921; http://dx.doi.org/10.2174/157488606775252575
   PubMedGoogle Scholar
• Yahya M. Polio vaccines- no thank you! Barriers to polio eradication in Northern Nigeria. African Affairs 2007; 106(423):185-204; http://dx.doi.org/10.1093/afraf/adm016
   Web of Science ®Google Scholar
• Kaufmann JR, Feldbaum H. Diplomacy and the polio immunization boycott in Northern Nigeria. Health Affairs (Project Hope) 2009; 28(4):1091-101; PMID:19597208; http://dx.doi.org/10.1377/hlthaff.28.4.1091
   PubMed Web of Science ®Google Scholar
• Renne E. Perspectives on polio and immunization in Northern Nigeria. Social Science & Medicine (1982) 2006; 63(7):1857-69; PMID:16765498; http://dx.doi.org/10.1016/j.socscimed.2006.04.025
   PubMed Web of Science ®Google Scholar
• Ghinai I, Willott C, Dadari I, Larson HJ. Listening to the rumours: what the northern Nigeria polio vaccine boycott can tell us ten years on. Global Public Health 2013; 8(10):1138-50; PMID:24294986; http://dx.doi.org/10.1080/17441692.2013.859720
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay, Ananda S., et al. Polio vaccination: past, present and future. Future Microbiology 2015; 10(5):791-808.
   PubMed Web of Science ®Google Scholar